Deconex Ir Tablet
NDC Package 50991-736-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Deconex Ir (guaifenesin and phenylephrine hcl) tablets is adults and children 12 years of age and older: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours.Children age 6 to 12 years of age: 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours or as directed by a doctor.Children 6 years of age and younger: Consult a physician. This formulation utilizes a tablet delivery system. Marketed by Poly Pharmaceuticals, Inc., this product is identified by NDC 50991-736 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
50991-736-90
Package Description
1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE
Product Code
50991-736
11-Digit Billing Format
50991073690
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1805155 - guaiFENesin 385 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1805155 - guaifenesin 385 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Deconex Ir
Non-Proprietary Name
Guaifenesin And Phenylephrine Hcl
Substance Name
Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 12 years of age and older: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours.Children age 6 to 12 years of age: 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours or as directed by a doctor.Children 6 years of age and younger: Consult a physician.

Regulatory & Marketing

Labeler Name
Poly Pharmaceuticals, Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-08-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50991-736). Click a package code to view its specific billing and regulatory data.

50991-736-02
12 BLISTER PACK in 1 CARTON / 2 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50991-736-90 identifies a specific commercial package of 1 bottle in 1 carton / 90 tablet in 1 bottle of Deconex Ir, a human over the counter drug labeled by Poly Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Poly Pharmaceuticals, Inc. on August 08, 2016. The current certification is valid through December 31, 2026.

How is this Poly Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50991073690. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50991-736-90
11-Digit CMS (5-4-2)
50991-0736-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.